Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association. Bertsias GK, et al. Among authors: praga m. Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31. Ann Rheum Dis. 2012. PMID: 22851469 Free PMC article.
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT. Fanouriakis A, et al. Among authors: praga m. Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27. Ann Rheum Dis. 2020. PMID: 32220834
European consensus statement on the terminology used in the management of lupus glomerulonephritis.
Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, Ballerin J, Cervera R, Calvo-Alén J, Chizzolini C, Dayer J, Doria A, Ferrario F, Floege J, Guillevin L, Haubitz M, Hiepe F, Houssiau F, Lesavre P, Lightstone L, Meroni P, Meyer O, Moulin B, O'Reilly K, Praga M, Schulze-Koops H, Sinico R, Smith K, Tincani A, Vasconcelos C, Hughes G. Gordon C, et al. Among authors: praga m. Lupus. 2009 Mar;18(3):257-63. doi: 10.1177/0961203308100481. Lupus. 2009. PMID: 19213865
Treatment for refractory lupus nephritis: Rituximab vs triple target therapy.
Cervera R, Mosca M, Ríos-Garcés R, Espinosa G, Trujillo H, Bada T, Praga M. Cervera R, et al. Among authors: praga m. Autoimmun Rev. 2019 Dec;18(12):102406. doi: 10.1016/j.autrev.2019.102406. Epub 2019 Oct 22. Autoimmun Rev. 2019. PMID: 31654743 Review. No abstract available.
Update on Lupus Nephritis: Looking for a New Vision.
Morales E, Galindo M, Trujillo H, Praga M. Morales E, et al. Among authors: praga m. Nephron. 2021;145(1):1-13. doi: 10.1159/000511268. Epub 2020 Nov 4. Nephron. 2021. PMID: 33147587 Review.
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.
Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators. Fellström BC, et al. Among authors: praga m. Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28. Lancet. 2017. PMID: 28363480 Free article. Clinical Trial.
Mycophenolate in refractory and relapsing lupus nephritis.
Rivera F, Mérida E, Illescas ML, López-Rubio E, Frutos MA, García-Frías P, Ramos C, Sierra M, Baltar J, Lucas J, Oliet A, Vigil A, Fernández-Juárez G, Segarra A, Praga M; Glomerular Spanish Glomerular Study Group (GLOSEN). Rivera F, et al. Among authors: praga m. Am J Nephrol. 2014;40(2):105-12. doi: 10.1159/000365256. Epub 2014 Jul 30. Am J Nephrol. 2014. PMID: 25096639
Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines.
Lledó GM, Xipell M, García-Herrera A, Bueno L, Cervera R, Galindo M, Gómez-Puerta JA, Morales E, Praga M, Rojas JE, Ruiz-Irastorza G, Pernaute OS, Jayne D, Espinosa G, Quintana LF; Multidisciplinary Group for the Study of Lupus Nephritis. Lledó GM, et al. Among authors: praga m. Eur J Intern Med. 2022 May;99:19-21. doi: 10.1016/j.ejim.2022.03.016. Epub 2022 Mar 19. Eur J Intern Med. 2022. PMID: 35317963 No abstract available.
Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi Survey.
Floege J, Gibson KL, Praga M, Radhakrishnan J, Reich HN, Schreuder MF, Wetzels JF, Tesař V, Vivarelli M, Biechele S, Tonelli M. Floege J, et al. Among authors: praga m. Kidney Int Rep. 2022 Jun 23;7(9):2081-2085. doi: 10.1016/j.ekir.2022.06.010. eCollection 2022 Sep. Kidney Int Rep. 2022. PMID: 36090486 Free PMC article. No abstract available.
418 results